Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Thumbnail

High-sensitivity troponin protocol most successful at freestanding EDs

Freestanding EDs demonstrated meaningful operational advantages over hospitals when using an accelerated troponin pathway. This included earlier discharges for low-risk chest pain patients.

claire perimeter medical imaging

FDA approves 1st AI-enabled imaging device for breast cancer surgery

Manufacturer Perimeter Medical Imaging announced the news on March 3 after earning premarket approval for “Claire” (formerly the Perimeter OCT B-Series). 

Bayer's MR contrast injection system cleared by FDA for expanded use

The updated clearance expands the system's labeled field strength compatibility; the change will allow MRI suites with scanners up to the 7T range to utilize the system.

money maze payment reimbursement

AI-enabled lesion quantification tool earns new CPT code

The software gives clinicians detailed insight into how patients are responding to treatment based on changes in lesion size and metabolic activity, offering earlier opportunities to alter care plans.  

Thumbnail

Society of Interventional Radiology offers new guidance for treating chronic pelvic pain

The new guidelines focus on pelvic venous disorders, which can cause a wide array of painful symptoms.

Medicare money bills dollars

Radiology societies fight Medicare Administrative Contractor’s proposed coverage restriction

National Government Services is seeking to limit the use of thermal destruction of the intraosseous basivertebral nerve, aka the Intracept procedure, drawing ire from ACR and SIR. 

mergers and acquisitions M&A consolidation puzzle business deal

Company seeks to become a ‘leader in interventional radiology’ with recent acquisition

Quantum Surgical, which specializes in minimally invasive, robotic-assisted cancer care, recently reached a deal to acquire NeuWave Medical, previously held by J&J. 

Lantheus receives tentative FDA approval for its radio-equivalent to Lutathera

Lantheus’ version of a radiopharmaceutical capable of targeting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has been tentatively approved by the FDA.